{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T20:38:21Z","timestamp":1795207101604,"version":"4.10.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2025,10,5]]},"DOI":"10.1038\/s41416-025-03106-1","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T17:55:27Z","timestamp":1752774927000},"page":"809-822","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Targeting gut microbiota and arginase boosts MEK inhibitors\u2019 enhancement of antitumour immunity via MHC-I upregulation in colorectal cancer"],"prefix":"10.1038","volume":"133","author":[{"given":"Jingdan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liumei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxiong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengchen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5445-9313","authenticated-orcid":false,"given":"Emile Z.","family":"Naccasha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5881-4299","authenticated-orcid":false,"given":"Xiangling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4416-116X","authenticated-orcid":false,"given":"Chuangyu","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"3106_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3106_CR2","first-page":"599","volume":"17","author":"WA Messersmith","year":"2019","unstructured":"Messersmith WA. Nccn guidelines updates: management of metastatic colorectal cancer. J Natl Compr Cancer Netw. 2019;17:599\u2013601.","journal-title":"J Natl Compr Cancer Netw"},{"key":"3106_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/jamaoncol.2017.2899","volume":"4","author":"A Zaanan","year":"2018","unstructured":"Zaanan A, Shi Q, Taieb J, Alberts SR, Meyers JP, Smyrk TC, et al. Role of deficient DNA mismatch repair status in patients with stage iii colon cancer treated with folfox adjuvant chemotherapy: a pooled analysis from 2 randomized clinical trials. JAMA Oncol. 2018;4:379\u201383.","journal-title":"JAMA Oncol"},{"key":"3106_CR4","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","volume":"21","author":"S Jhunjhunwala","year":"2021","unstructured":"Jhunjhunwala S, Hammer C, Delamarre L. Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion. Nat Rev Cancer. 2021;21:298\u2013312.","journal-title":"Nat Rev Cancer"},{"key":"3106_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nri.2017.143","volume":"18","author":"CA Dendrou","year":"2018","unstructured":"Dendrou CA, Petersen J, Rossjohn J, Fugger L. Hla variation and disease. Nat Rev Immunol. 2018;18:325\u201339.","journal-title":"Nat Rev Immunol"},{"key":"3106_CR6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ccell.2019.08.008","volume":"36","author":"ML Burr","year":"2019","unstructured":"Burr ML, Sparbier CE, Chan KL, Chan YC, Kersbergen A, Lam EYN, et al. An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer. Cancer Cell. 2019;36:385\u2013401.e8.","journal-title":"Cancer Cell"},{"key":"3106_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01833-8","volume":"22","author":"P Stachura","year":"2023","unstructured":"Stachura P, Liu W, Xu HC, Wlodarczyk A, Stencel O, Pandey P, et al. Unleashing T cell anti-tumor immunity: new potential for 5-nonloxytryptamine as an agent mediating MHC-I upregulation in tumors. Mol Cancer. 2023;22:136.","journal-title":"Mol Cancer"},{"key":"3106_CR8","first-page":"603","volume":"3","author":"DA Franklin","year":"2020","unstructured":"Franklin DA, James JL, Axelrod ML, Balko JM. MEK inhibition activates stat signaling to increase breast cancer immunogenicity via MHC-I expression. Cancer Drug Resist. 2020;3:603\u201312.","journal-title":"Cancer Drug Resist"},{"key":"3106_CR9","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1158\/2326-6066.CIR-21-0147","volume":"9","author":"L Dennison","year":"2021","unstructured":"Dennison L, Ruggieri A, Mohan A, Leatherman J, Cruz K, Woolman S, et al. Context-dependent immunomodulatory effects of MEK inhibition are enhanced with T-cell agonist therapy. Cancer Immunol Res. 2021;9:1187\u2013201.","journal-title":"Cancer Immunol Res"},{"key":"3106_CR10","doi-asserted-by":"publisher","first-page":"e2208900119","DOI":"10.1073\/pnas.2208900119","volume":"119","author":"LE Stopfer","year":"2022","unstructured":"Stopfer LE, Rettko NJ, Leddy O, Mesfin JM, Brown E, Winski S, et al. MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas. Proc Natl Acad Sci USA. 2022;119:e2208900119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3106_CR11","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1126\/science.abb5920","volume":"371","author":"EN Baruch","year":"2021","unstructured":"Baruch EN, Youngster I, Ben-Betzalel G, Ortenberg R, Lahat A, Katz L, et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science. 2021;371:602\u20139.","journal-title":"Science"},{"key":"3106_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.955313","volume":"12","author":"YC Chen","year":"2022","unstructured":"Chen YC, Chuang CH, Miao ZF, Yip KL, Liu CJ, Li LH, et al. Gut microbiota composition in chemotherapy and targeted therapy of patients with metastatic colorectal cancer. Front Oncol. 2022;12:955313.","journal-title":"Front Oncol"},{"key":"3106_CR13","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.cmet.2021.03.002","volume":"33","author":"Y He","year":"2021","unstructured":"He Y, Fu L, Li Y, Wang W, Gong M, Zhang J, et al. Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8(+) T cell immunity. Cell Metab. 2021;33:988\u20131000.e7.","journal-title":"Cell Metab"},{"key":"3106_CR14","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13046-020-01801-w","volume":"39","author":"N Trivieri","year":"2020","unstructured":"Trivieri N, Pracella R, Cariglia MG, Panebianco C, Parrella P, Visioli A, et al. BRAF(V600E) mutation impinges on gut microbial markers defining novel biomarkers for serrated colorectal cancer effective therapies. J Exp Clin Cancer Res. 2020;39:285.","journal-title":"J Exp Clin Cancer Res"},{"key":"3106_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453\u20137.","journal-title":"Nat Methods"},{"key":"3106_CR16","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1016\/j.cell.2023.07.016","volume":"186","author":"X Chen","year":"2023","unstructured":"Chen X, Lu Q, Zhou H, Liu J, Nadorp B, Lasry A, et al. A membrane-associated MHC-I inhibitory axis for cancer immune evasion. Cell. 2023;186:3903\u201320.e21.","journal-title":"Cell"},{"key":"3106_CR17","doi-asserted-by":"crossref","unstructured":"Wang Y, Wang X, Cui X, Zhuo Y, Li H, Ha C, et al. Oncoprotein SND1 hijacks nascent MHC-I heavy chain to er-associated degradation, leading to impaired CD8(+) T cell response in tumor. Sci Adv. 2020;6:eaba5412.","DOI":"10.1126\/sciadv.aba5412"},{"key":"3106_CR18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1158\/2159-8290.CD-19-0672","volume":"10","author":"DA Erkes","year":"2020","unstructured":"Erkes DA, Cai W, Sanchez IM, Purwin TJ, Rogers C, Field CO, et al. Mutant braf and mek inhibitors regulate the tumor immune microenvironment via pyroptosis. Cancer Discov. 2020;10:254\u201369.","journal-title":"Cancer Discov"},{"key":"3106_CR19","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1158\/1541-7786.MCR-17-0404","volume":"16","author":"P Zhang","year":"2018","unstructured":"Zhang P, Kawakami H, Liu W, Zeng X, Strebhardt K, Tao K, et al. Targeting CDK1 and MEK\/ERK overcomes apoptotic resistance in braf-mutant human colorectal cancer. Mol Cancer Res. 2018;16:378\u201389.","journal-title":"Mol Cancer Res"},{"key":"3106_CR20","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1158\/2159-8290.CD-20-0812","volume":"11","author":"SS Gu","year":"2021","unstructured":"Gu SS, Zhang W, Wang X, Jiang P, Traugh N, Li Z, et al. Therapeutically increasing MHC-I expression potentiates immune checkpoint blockade. Cancer Discov. 2021;11:1524\u201341.","journal-title":"Cancer Discov"},{"key":"3106_CR21","doi-asserted-by":"publisher","first-page":"13794","DOI":"10.1073\/pnas.1008684107","volume":"107","author":"TB Meissner","year":"2010","unstructured":"Meissner TB, Li A, Biswas A, Lee KH, Liu YJ, Bayir E, et al. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proc Natl Acad Sci USA. 2010;107:13794\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3106_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.trecan.2016.12.003","volume":"3","author":"S Yoshihama","year":"2017","unstructured":"Yoshihama S, Vijayan S, Sidiq T, Kobayashi KS. NLRC5\/CITA: a key player in cancer immune surveillance. Trends Cancer. 2017;3:28\u201338.","journal-title":"Trends Cancer"},{"key":"3106_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrc3409","volume":"13","author":"Y Yang","year":"2013","unstructured":"Yang Y, Bedford MT. Protein arginine methyltransferases and cancer. Nat Rev Cancer. 2013;13:37\u201350.","journal-title":"Nat Rev Cancer"},{"key":"3106_CR24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1158\/1541-7786.MCR-20-0745","volume":"19","author":"T Sapir","year":"2021","unstructured":"Sapir T, Shifteh D, Pahmer M, Goel S, Maitra R. Protein arginine methyltransferase 5 (PRMT5) and the ERK1\/2 & PI3K pathways: a case for PRMT5 inhibition and combination therapies in cancer. Mol Cancer Res. 2021;19:388\u201394.","journal-title":"Mol Cancer Res"},{"key":"3106_CR25","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41575-019-0209-8","volume":"16","author":"SH Wong","year":"2019","unstructured":"Wong SH, Yu J. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat Rev Gastroenterol Hepatol. 2019;16:690\u2013704.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3106_CR26","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s13238-020-00813-8","volume":"12","author":"A Wong-Rolle","year":"2021","unstructured":"Wong-Rolle A, Wei HK, Zhao C, Jin C. Unexpected guests in the tumor microenvironment: microbiome in cancer. Protein Cell. 2021;12:426\u201335.","journal-title":"Protein Cell"},{"key":"3106_CR27","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nri.2016.42","volume":"16","author":"MG Rooks","year":"2016","unstructured":"Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 2016;16:341\u201352.","journal-title":"Nat Rev Immunol"},{"key":"3106_CR28","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","volume":"167","author":"R Geiger","year":"2016","unstructured":"Geiger R, Rieckmann JC, Wolf T, Basso C, Feng Y, Fuhrer T, et al. L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity. Cell. 2016;167:829\u201342.e13.","journal-title":"Cell"},{"key":"3106_CR29","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez VM, Arteaga A, Dunn MF. Diversity, properties and functions of bacterial arginases. FEMS Microbiol Rev. 2021;45:fuab034.","DOI":"10.1093\/femsre\/fuab034"},{"key":"3106_CR30","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18:248\u201362.","journal-title":"Cell Rep"},{"key":"3106_CR31","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41586-020-2229-5","volume":"581","author":"K Yamamoto","year":"2020","unstructured":"Yamamoto K, Venida A, Yano J, Biancur DE, Kakiuchi M, Gupta S, et al. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature. 2020;581:100\u201305.","journal-title":"Nature"},{"key":"3106_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51784-x","volume":"15","author":"M Jalan","year":"2024","unstructured":"Jalan M, Sharma A, Pei X, Weinhold N, Buechelmaier ES, Zhu Y, et al. RAD52 resolves transcription-replication conflicts to mitigate R-loop induced genome instability. Nat Commun. 2024;15:7776.","journal-title":"Nat Commun"},{"key":"3106_CR33","doi-asserted-by":"crossref","unstructured":"Hung S, Saiakhova A, Faber ZJ, Bartels CF, Neu D, Bayles I, et al. Mismatch repair-signature mutations activate gene enhancers across human colorectal cancer epigenomes. Elife. 2019;8:e40760.","DOI":"10.7554\/eLife.40760"},{"key":"3106_CR34","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.7150\/thno.111625","volume":"15","author":"L Liu","year":"2025","unstructured":"Liu L, Ba Y, Yang S, Zuo A, Liu S, Zhang Y, et al. FOS-driven inflammatory CAFs promote colorectal cancer liver metastasis via the SFRP1-FGFR2-HIF1 axis. Theranostics. 2025;15:4593\u2013613.","journal-title":"Theranostics"},{"key":"3106_CR35","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1158\/0008-5472.CAN-16-3247","volume":"77","author":"D Li","year":"2017","unstructured":"Li D, Bentley C, Anderson A, Wiblin S, Cleary KLS, Koustoulidou S, et al. Development of a T-cell receptor mimic antibody against wild-type p53 for cancer immunotherapy. Cancer Res. 2017;77:2699\u2013711.","journal-title":"Cancer Res"},{"key":"3106_CR36","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/s41586-023-06721-1","volume":"623","author":"A Malik","year":"2023","unstructured":"Malik A, Sharma D, Aguirre-Gamboa R, McGrath S, Zabala S, Weber C, et al. Epithelial IFN\u03b3 signalling and compartmentalized antigen presentation orchestrate gut immunity. Nature. 2023;623:1044\u201352.","journal-title":"Nature"},{"key":"3106_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202207366","volume":"10","author":"Q Yang","year":"2023","unstructured":"Yang Q, Wang B, Zheng Q, Li H, Meng X, Zhou F, et al. A review of gut microbiota-derived metabolites in tumor progression and cancer therapy. Adv Sci. 2023;10:e2207366.","journal-title":"Adv Sci"},{"key":"3106_CR38","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s43018-024-00775-4","volume":"5","author":"KM Tharp","year":"2024","unstructured":"Tharp KM, Kersten K, Maller O, Timblin GA, Stashko C, Canale FP, et al. Tumor-associated macrophages restrict CD8+ T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment. Nat Cancer. 2024;5:1045\u201362.","journal-title":"Nat Cancer"},{"key":"3106_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2022.100573","volume":"27","author":"X Wan","year":"2023","unstructured":"Wan X, Eguchi A, Sakamoto A, Fujita Y, Yang Y, Qu Y, et al. Impact of broad-spectrum antibiotics on the gut-microbiota-spleen-brain axis. Brain Behav Immun Health. 2023;27:100573.","journal-title":"Brain Behav Immun Health"},{"key":"3106_CR40","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41586-022-05438-x","volume":"611","author":"AB Smith","year":"2022","unstructured":"Smith AB, Jenior ML, Keenan O, Hart JL, Specker J, Abbas A, et al. Enterococci enhance clostridioides difficile pathogenesis. Nature. 2022;611:780\u201386.","journal-title":"Nature"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03106-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03106-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03106-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T09:53:33Z","timestamp":1758275613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03106-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,10,5]]}},"alternative-id":["3106"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03106-1","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"24 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent was obtained from the patients, and the protocol for using human blood samples was approved by the Institutional Review Board of the Sixth Affiliated Hospital of Sun Yat-sen University (2018ZSLYEC-008). The animal experiments in this study were evaluated and approved by the Institutional Animal Care and Use Committee (IACUC, NO: IACUC- 2022032701, 2021122201) of The Sixth Affiliated Hospital, Sun Yat\u2010sen University. All analyses were conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}